Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment

R. A. Werner, J. S. Schmid, D. O. Muegge, K. Lückerath, T. Higuchi, H. Hänscheid, I. Grelle, C. Reiners, K. Herrmann, A. K. Buck, C. Lapa

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences